Erica C.
- Country
- Italy
- Department
- S.C. Neurologia
Research Overview
- A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis
- A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE IN ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
Data & Insights
Has run more than one trial at 19 of 82 partner sites.
Specializations
Multiple Sclerosis Research
The investigator specializes in the clinical evaluation of therapeutic approaches for different forms of multiple sclerosis, with particular emphasis on both relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
- Treatment Comparisons in RMS
- PPMS Therapeutic Interventions
- Novel Treatment Evaluation
The investigator focuses on assessing therapeutic efficacy in multiple sclerosis through comparative studies of emerging treatments.
Neurological Therapeutics
The investigator conducts research in neurological therapeutics, particularly examining innovative treatment options for progressive neurological conditions. Their work includes evaluation of BTK inhibitors and established therapeutic agents.
- Comparative Treatment Studies
- Disease Progression Assessment
- Treatment Response Evaluation
Their research encompasses comprehensive assessment of therapeutic efficacy and safety profiles in neurological conditions.
Clinical Outcomes
The investigator's work involves measuring clinical outcomes in neurological disorders, with specific focus on annualized relapse rates and disease progression markers in multiple sclerosis patients.
- Relapse Rate Assessment
- Treatment Efficacy Metrics
- Safety Profile Analysis
Their research emphasizes quantifiable clinical outcomes in neurological disease treatment evaluation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.